Characterization of endothelin-converting enzyme 1 as a key enzyme in the multienzyme Aβ degradation pathway
Open Access
- 27 October 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (44)
Abstract
Altered β-amyloid (Aβ) homeostasis is a critical event triggering the shift from healthy aging to Alzheimer disease (AD) through the overproduction and impaired clearance of Aβ peptides. The Aβ-degrading enzymes (ADEs) are a collective group of proteases that normally promote clearance to counteract Aβ-induced neurodegeneration. We previously discovered that the beta-site amyloid precursor protein cleaving enzyme 1 is an atypical ADE that produces the nontoxic fragment Aβ34 by recognizing 40- or 42-residue-long Aβ peptides as substrates in vitro and in vivo. Here, we examined other known ADEs for their potential roles in degrading Aβ34, Aβ40, and Aβ42. By genetic, cellular, and pharmacological approaches, we identified and characterized endothelin-converting enzyme 1 (ECE1) in a human neuroblastoma cell line, human brain vascular pericytes, and primary rat cortical cultures as a major enzyme degrading Aβ34 but not Aβ40 or Aβ42. Notably, we found that ECE1 cleaves Aβ34, an indicator of amyloid clearance, to a unique and unusually stable Aβ20-34 fragment that has the potential to serve as a measurable biomarker. Biocomputational analyses from non-AD controls and individuals with AD pathology showed that the highest messenger ribonucleic acid (mRNA) levels of ECE1 expression were found in pericytes (i.e., cells within the brain microvasculature that are known to produce Aβ34) compared to other cell types. Given Aβ34 is an indicator for prodromal AD, we postulate that our collective findings (i.e., generation of Aβ34 and Aβ20-34 intermediates within the “amyloidolytic” degradation pathway) will generate a set of biomarkers to detect amyloid clearance activity in vivo.Keywords
Funding Information
- Institute of Aging (185865)
This publication has 38 references indexed in Scilit:
- Inhibition of BACE1 affected both its Aβ producing and degrading activities and increased Aβ42 and Aβ40 levels at high-level BACE1 expressionJournal of Biological Chemistry, 2024
- Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer’s disease pathologyCell, 2023
- Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's DiseaseNeurotherapeutics, 2022
- Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?Journal of Biological Chemistry, 2021
- Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s diseaseActa Neuropathologica, 2014
- Study on Aβ34 biology and detection in transgenic mice brainsNeurobiology of Aging, 2014
- Developments in neuronal cell cultureNature, 1988
- Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.Journal of Biological Chemistry, 1986
- Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.The EMBO Journal, 1985
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967